Prodesse, Inc. today announced the commercial release of its ProFlu-1assay. From a single patient sample, this assay will detect and differentiate Influenza A, Influenza B and Respiratory Syncytial Virus (RSV). The Real Time technology used in ProFlu-1 makes the detection process faster and easier than conventional molecular diagnostic techniques.
